The first and only soft bait product featuring breakthrough, next generation technology that targets rodent populations by using nonlethal methods to restrict fertility.
Author Archive: AZBio
Ivy Center Announces First Patient Treated in Targeted Phase 0/1 Clinical Trial for High-Grade Glioma
Study tests targeted agent, BDTX-1535, an EGFR inhibitor with brain-penetrant properties Continue reading
ASU researchers working to develop biomarkers to screen for HPV-related cancer
Oropharyngeal cancer — a type of cancer that is difficult to diagnose, treat — is on the rise
Recent studies have highlighted a concerning trend: a rise in oropharyngeal cancer — difficult to diagnose and difficult to treat — linked to the human papillomavirus (HPV). Researchers are keen to spread awareness about this connection, emphasizing the importance of HPV vaccinations for both men and women and expanded testing for those at risk.Continue reading
$13M NIH grant funds research aimed at revitalizing immune systems of older adults
A $13 million NIH grant will fund three projects designed to help researchers learn more about how T cells are created and maintained and create interventions to improve immune defense.Continue reading
College Sets New Course as Dean Wondisford is Officially Welcomed
Reception introduced Dean Fred Wondisford to the college’s family and extended gratitude to former dean Guy Reed, MD, MS, for his contributionsContinue reading
ASU study: Mutations in critical gene may steer health outcomes in breast cancer
Despite enormous progress, breast cancer remains elusive, perplexing and, often, deadly. The disease can emerge due to a complex interplay of factors, including lifestyle, environment, aging and genetic predisposition.Continue reading
MIT Validates Serva Energy’s Novel Production Method of Life-saving Actinium-225 Isotope
Serva Energy’s sample measurement of the rare, cancer-killing medical isotope Actinium-225 has been validated by the Massachusetts Institute of Technology (MIT) Nuclear Research Laboratory.
It’s the latest milestone in Serva’s development of commercial quantities of Actinium-225 (Ac-225) needed for next-generation Targeted Alpha Therapies.Continue reading
Groundbreaking study reveals link between air pollution and incidence of Parkinson’s disease
A new study led by researchers at Barrow Neurological Institute has found that people living in regions with median levels of air pollution have a 56 percent greater risk of developing Parkinson’s disease compared to those living in regions with the lowest level of air pollution.Continue reading
Rampart Bioscience Announces $85M Series A Financing to Develop Novel DNA-Based Medicines with Veteran Team
Forbion leads Series A, with participation from founding seed investor OrbiMed and additional new investors RA Capital Management and HealthCap